NL-OMON53393尚未招募4 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel - CARTinue
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Subjects who have received at least one dose of cilta-cel in a
- •Company-sponsored clinical study.
- •2. Subjects who have provided informed consent for Study MMY4002.
排除标准
- •No exclusion criteria are applicable in this study.
研究者
相似试验
招募中
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMedDRA version: 21.0Level: LLTClassification code: 10028228Term: Multiple myeloma Class: 10029104Multiple MyelomaCTIS2023-505530-10-00Janssen - Cilag International365
进行中（未招募）
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMultiple MyelomaEUCTR2020-005521-84-ESJanssen-Cilag International NV400
进行中（未招募）
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2020-005521-84-NLJanssen-Cilag International NV400
招募中
3 期
A Long-term Study for Participants Previously Treated with Ciltacabtagene AutoleucelMultiple MyelomaJPRN-jRCT2033220220Ei Fujikawa228
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for X-linked Retinitis PigmentosaEUCTR2018-000425-31-Outside-EU/EEAJanssen-Cilag International NV